Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson's disease mice model

被引:53
作者
Motawi, Tarek K. [1 ]
Sadik, Nermin A. H. [1 ]
Hamed, Manal A. [2 ]
Ali, Sanaa A. [2 ]
Khalil, Wagdy K. B. [3 ]
Ahmed, Yomna R. [2 ]
机构
[1] Cairo Univ, Fac Pharm, Biochem Dept, Cairo, Egypt
[2] Natl Res Ctr, Dept Therapeut Chem, El Buhouth St, Giza 12622, Egypt
[3] Natl Res Ctr, Cell Biol Dept, El Buhouth St, Giza 12622, Egypt
关键词
Curcumin; Niacin; Rotenone; Parkinson's disease; ZM241385; ALPHA-SYNUCLEIN; DNA-DAMAGE; BRAIN; EXPRESSION; TISSUE; INFLAMMATION; MECHANISMS; INHIBITION; REDUCTION; CAFFEINE;
D O I
10.1007/s11010-019-03670-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease (PD) is the second common age-related neurodegenerative disease. It is characterized by control loss of voluntary movements control, resting tremor, postural instability, bradykinesia, and rigidity. The aim of the present work is to evaluate curcumin, niacin, dopaminergic and non-dopaminergic drugs in mice model of Parkinson's disease through behavioral, biochemical, genetic and histopathological observations. Mice treated with rotenone rerecorded significant increase in adenosine A(2A) receptor (A(2A)R) gene expression, alpha synuclein, acetylcholinesterase (AchE), malondialdehyde (MDA), angiotensin-II (Ang-II), c-reactive protein (CRP), interleukin-6 (IL-6), caspase-3 (Cas-3) and DNA fragmentation levels as compared with the control group. While, significant decrease in dopamine (DA), norepinephrine (NE), serotonin (5-HT), superoxide dismutase (SOD), reduced glutathione (GSH), ATP, succinate and lactate dehydrogenases (SDH &LDH) levels were detected. Treatment with curcumin, niacin, adenosine A(2A)R antagonist; ZM241385 and their combination enhanced the animals' behavior and restored all the selected parameters with variable degrees of improvement. The brain histopathological features of hippocampal and substantia nigra regions confirmed our results. In conclusion, the combination of curcumin, niacin and ZM241385 recorded the most potent treatment effect in Parkinsonism mice followed by ZM241385, as a single treatment. ZM241385 succeeded to antagonize adenosine A(2A) receptor by diminishing its gene expression and ameliorating all biochemical parameters under investigation. The newly investigated agent; ZM241385 has almost the same pattern of improvement as the classical drug; Sinemet (R). This could shed the light to the need of detailed studies on ZM241385 for its possible role as a promising treatment against PD. Additionally, food supplements such as curcumin and niacin were effective in Parkinson's disease eradication.
引用
收藏
页码:89 / 102
页数:14
相关论文
共 79 条
[1]   L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats [J].
Alam, M ;
Schmidt, WJ .
BEHAVIOURAL BRAIN RESEARCH, 2004, 153 (02) :439-446
[2]  
[Anonymous], 2014, CELL BIOL RES THER
[3]   Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].
Ascherio, A ;
Zhang, SMM ;
Hernán, MA ;
Kawachi, I ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63
[4]  
BABSON AL, 1973, CLIN CHEM, V19, P766
[5]  
Bancroft J, 1996, THEORY PRACTICE HIST, P40
[6]   Angiotensin II revisited: new roles in inflammation, immunology and aging [J].
Benigni, Ariela ;
Cassis, Paola ;
Remuzzi, Giuseppe .
EMBO MOLECULAR MEDICINE, 2010, 2 (07) :247-257
[7]   IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease [J].
Bessler, H ;
Djaldetti, R ;
Salman, H ;
Bergman, M ;
Djaldetti, M .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) :141-145
[8]   Animal models of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
Greenamyre, JT .
BIOESSAYS, 2002, 24 (04) :308-318
[9]   Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias [J].
Calon, F ;
Dridi, M ;
Hornykiewicz, O ;
Bédard, PJ ;
Rajput, AH ;
Di Paolo, T .
BRAIN, 2004, 127 :1075-1084
[10]   A highly reproducible rotenone model of Parkinson's disease [J].
Cannon, Jason R. ;
Tapias, Victor ;
Na, Hye Mee ;
Honick, Anthony S. ;
Drolet, Robert E. ;
Greenamyre, J. Timothy .
NEUROBIOLOGY OF DISEASE, 2009, 34 (02) :279-290